Concepedia

Sue‐Ing Lin

SL

Statistics

Publications

13

Citations

580

H-Index

11

Active since

1987

Affiliations

Duke University(Current)

Sue‐Ing Lin is an author at Duke University specializing in medicinal chemistry, pharmacology, and drug discovery.

Publications per year

1987–2017

13

Publications

13

Discovery of a 3-(4-Pyrimidinyl) Indazole (MLi-2), an Orally Available and Selective Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitor that Reduces Brain Kinase Activity

Jack D. Scott, Duane E. DeMong, Thomas J. Greshock et al. · Journal of Medicinal Chemistry · 2017 · 148 citations · Full text

, , +16

Piperazine-Based CCR5 Antagonists as HIV-1 Inhibitors. II. Discovery of 1-[(2,4-Dimethyl-3-pyridinyl)carbonyl]-4- methyl-4-[3(<i>S</i>)-methyl-4-[1(<i>S</i>)-[4-(trifluoro- methyl)phenyl]ethyl]-1-piperazinyl]- piperidine <i>N</i>1-Oxide (Sch-350634), an Orally Bioavailable, Potent CCR5 Antagonist

Jayaram R. Tagat, Ruo W. Steensma, Stuart W. McCombie et al. · Journal of Medicinal Chemistry · 2001 · 113 citations · Full text

, , +17

Piperazine-Based CCR5 antagonists as HIV-1 inhibitors. I: 2(S)-methyl piperazine as a key pharmacophore element

Jayaram R. Tagat, Stuart W. McCombie, Ruo W. Steensma et al. · Bioorganic & Medicinal Chemistry Letters · 2001 · 65 citations · Full text

, , +9

Piperazine-based CCR5 antagonists as HIV-1 inhibitors. III: synthesis, antiviral and pharmacokinetic profiles of symmetrical heteroaryl carboxamides

Stuart W. McCombie, Jayaram R. Tagat, Susan F. Vice et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 52 citations · Full text

, , +14

Controlling benzylic functionality and stereochemistry: 1. Synthesis of the secopseudopterosin aglycone

Stuart W. McCombie, Brian Cox, Sue‐Ing Lin et al. · Tetrahedron Letters · 1991 · 48 citations · Full text

, , +10

1–5 of 13